HIV-Related Cardiovascular Disease: Albany Med

April 22, 2026

Target Audience

All pharmacists

Learning Objectives

 

At the completion of the activity, the participant will be able to:

Understand the pathophysiology underlying cardiovascular disease in HIV
Review strategies for preventing HIV-associated cardiovascular disease
Consider the role of inflammation in HIV and strategies to lower inflammation as a means to reduce cardiovascular risk

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
04/17/2026
Course expires: 
11/24/2028
Event starts: 
04/22/2026 - 12:00pm EDT
Event ends: 
04/22/2026 - 1:00pm EDT
Cost:
$0.00
Rating: 
0
Via Webcast
United States
  • Priscilla Hsue, MD- Bio
  • Dr. Priscilla Hsue is Chief of Cardiology, UCLA , the Chizuko and Nobuyuki Kawata Chair in Cardiology, and Professor of Medicine at the David Geffen School of Medicine, UCLA. 
  • She completed her medical degree, internal medicine residency and cardiology fellowship training at UCSF where she had been on faculty since 2002-2024 and was the Maurice Eliaser Jr. MD Distinguished Professor of Medicine and Chief of Cardiology, UCSF at Zuckerberg San Francisco General Hospital.
  • Dr. Hsue discovered higher rates of cardiovascular disease in HIV and then elucidated the mechanism underlying this disease process. Her work demonstrated the role of chronic inflammation and immune activation in treated HIV which has been shown to be strongly predictive of clinical events and mortality. As a pioneer of HIV cardiology, her body of work continues to be multidisciplinary, innovative, and paradigm shifting in medicine.
  • Dr. Hsue leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID. Her groundbreaking work includes clinical trials of anti-inflammatory, immunomodulatory, and lipid-lowering therapies, not only in the context of HIV but also in areas such as rheumatoid arthritis, atherosclerosis, and most recently, COVID-19.

Since 2005, Dr. Hsue has been a continuous recipient of NIH funding, serving as principal investigator (PI) and co-investigator (Co-I) on numerous NIH grants. Her extensive contributions to the field are reflected in publications in prestigious

  • journals, including the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, JAMA Cardiology, Clinical Infectious Diseases, and AIDS.
  • Beyond her research, Dr. Hsue has played pivotal roles in various advisory and leadership positions, such as chair of the Clinical and Integrative Cardiovascular Science and chair of the Single-Site and Pilot Clinical Trials Study Sections at the National Heart, Lung, and Blood Institute. She has previously served on the Office of AIDS Research Advisory Council at NIH.
  • She is also an elected member and President of the American Society of Clinical Investigation (ASCI). She is a fellow of the American Heart Association and the American College of Cardiology, a member of the Association of University Cardiologists, a member of the Association of American Physicians, and Vice-Chair of the Sarnoff Scientific Committee. In 2025, she joined the American Heart Association Greater Los Angeles Board of Directors.
  • She has had the privilege of mentoring numerous students, trainees and faculty, has a 10-year K24 grant for mentoring from the National Institute of Allergy and Infectious Diseases, and has been recognized by multiple mentoring awards during her career. 

ACPE UAN # 0042-0000-26-020-L02-P

 
 
 

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.